ScholarIQanswers from OpenAlex
Psoriasis: Treatment and Pathogenesis
TopicLeading institutions, researchers & key papers
Psoriasis: Treatment and Pathogenesis is a topic indexed in ScholarIQ from OpenAlex.
What is known about Psoriasis: Treatment and Pathogenesis?
ScholarIQrecord summary
This cluster of papers focuses on the reciprocal developmental pathways for the generation of pathogenic effector TH17 cells and regulatory T cells, particularly in the context of autoimmune inflammation, interleukin-23, psoriasis, and the role of cytokines such as TGF-ß. It also explores the differentiation, cytokine profile, and function of human interleukin 17–producing helper T cells.
How many works does Psoriasis: Treatment and Pathogenesis have?
ScholarIQindexed works
Psoriasis: Treatment and Pathogenesis has 566 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Psoriasis: Treatment and Pathogenesis?
ScholarIQopenalex
The OpenAlex for Psoriasis: Treatment and Pathogenesis is on the source record.
What are the most-cited papers on Psoriasis: Treatment and Pathogenesis?
ScholarIQmost cited works
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Yan Zheng, Patricia Valdez, Dimitry M. Danilenko, Yan Hu, M. Logan Susan, Qian Gong, Alexander R. Abbas, Zora Modrušan, Nico Ghilardi, Frédéric J. de Sauvage, Wenjun Ouyang
Risk of Myocardial Infarction in Patients With Psoriasis
Joel M. Gelfand, Andrea L. Neimann, Daniel B. Shin, Xingmei Wang, David J. Margolis, Andrea B. Troxel
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi, Alexa B. Kimball, Kim Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T. Dooley, Kenneth B. Gordon
Phenotypic and functional features of human Th17 cells
Francesco Annunziato, Lorenzo Cosmi, Veronica Santarlasci, Laura Maggi, Francesco Liotta, Benedetta Mazzinghi, Eliana Parente, Lucia Filì, Simona Ferri, Francesca Frosali, Francesco Giudici, Paola Romagnani, Paola Parronchi, Francesco Tonelli, Enrico Maggi, Sergio Romagnani
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng, Dimitry M. Danilenko, Patricia Valdez, Ian Kasman, Jeffrey Eastham‐Anderson, Jianfeng Wu, Wenjun Ouyang
Where is Psoriasis: Treatment and Pathogenesis research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Psoriasis: Treatment and Pathogenesis is open access?
ScholarIQopen access share
40%OPEN ACCESS